UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma (original) (raw)

Prognostic value of quantitative immune alterations in melanoma patients

A. Tres

Oncología (Barcelona), 2006

View PDFchevron_right

Melanoma and immunotherapy bridge 2015

Angel Rivera

Journal of Translational Medicine, 2016

View PDFchevron_right

Ultraviolet radiation and the skin immune response

I. Sjerobabski-Masnec

ACTA CLINICA …, 2003

View PDFchevron_right

Current and emerging treatment options for uveal melanoma

Li-anne Lim

Clinical Ophthalmology, 2013

View PDFchevron_right

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

Luis Real

Cancer Immunology, Immunotherapy, 2001

View PDFchevron_right

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma

Abdallah Badou

Frontiers in Immunology, 2023

View PDFchevron_right

Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study

Janice Austin

Annals of Surgical Oncology, 2020

View PDFchevron_right

Local irradiation of murine melanoma affects the development of tumour-specific immunity

William Mcbride

Immunology, 2009

View PDFchevron_right

Immunologic escape and angiogenesis in human malignant melanoma

Pedro Redondo

Journal of the American Academy of Dermatology, 2003

View PDFchevron_right

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

Olga Vornicova

International Journal of Molecular Sciences, 2023

View PDFchevron_right

Can ultraviolet radiation act as a survival enhancer for cutaneous melanoma?

Cristina Fortes

European Journal of Cancer Prevention, 2016

View PDFchevron_right

Expression of COX-2 and Prognostic Outcome in Uveal Melanoma

Lorna Cryan

Current Eye Research, 2008

View PDFchevron_right

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Genny Del Zotto

Journal of Translational Medicine, 2018

View PDFchevron_right

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Wolfram Samlowski, Sancy Leachman

Pigment Cell & Melanoma Research, 2009

View PDFchevron_right

Supplementary Table 2 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Markus Frank

2023

View PDFchevron_right

Tumor screening and biology in malignant melanomas

Salvador J Diaz-Cano

2000

View PDFchevron_right

Impairment of antigen-presenting cell function by ultraviolet radiation

Mark Greene

Proceedings of the National Academy of Sciences of the United States of America, 1979

View PDFchevron_right

Supplementary Table 3 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Markus Frank

2023

View PDFchevron_right

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients

Cristina Fortes

Journal of Cancer Research and Clinical Oncology, 2021

View PDFchevron_right

Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma

Jens Kiilgaard

Annals of Oncology, 2019

View PDFchevron_right

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma

Giuseppe Palmieri

Frontiers in Oncology

View PDFchevron_right

Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort Study

Janice Austin

Annals of Surgical Oncology, 2020

View PDFchevron_right

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

asma gati

Cancer Immunology, Immunotherapy, 2006

View PDFchevron_right

Population-Based Incidence of Uveal Melanoma in Various Races and Ethnic Groups

Susan Schneider

American Journal of Ophthalmology, 2005

View PDFchevron_right

Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8

Mordechai Gutman

Melanoma Research, 1997

View PDFchevron_right

Differential Role of Basal Keratinocytes in UV-Induced Immunosuppression and Skin Cancer

George Garinis

Molecular and Cellular Biology, 2006

View PDFchevron_right

Immunotherapy Outcomes in Advanced Melanoma in Relation to Age

Issam Makhoul

The Permanente Journal, 2020

View PDFchevron_right

Characteristics of non-melanoma skin cancer depending upon occupational solar UV exposure dosage

Marc Wittlich

Romanian Medical Journal, 2020

View PDFchevron_right

Diagnosis, Histopathologic and Genetic Classification of Uveal Melanoma

Ruben Lopez

Melanoma - From Early Detection to Treatment, 2013

View PDFchevron_right

Altered molecular pathways in melanocytic lesions

Maria Scatolini

International Journal of Cancer, 2009

View PDFchevron_right

Genes and signaling pathways affecting the pathogenesis of melanoma

Bridget Varughese

Postdoc Journal, 2013

View PDFchevron_right

A Retrospective Study on the Risk of Non-Melanoma Skin Cancer in PUVA and Narrowband UVB Treated Patients

Ploysyne Busaracome

Archives of Clinical and Biomedical Research

View PDFchevron_right

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vincenzo Montesarchio

Journal of Translational Medicine

View PDFchevron_right

Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)

Ainara Soria

Annals of Translational Medicine, 2017

View PDFchevron_right

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”

Ena Wang

Journal of Translational Medicine, 2013

View PDFchevron_right